Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients.
about
Metabolomics: moving towards personalized medicineMicrobial, host and xenobiotic diversity in the cystic fibrosis sputum metabolomeMetabolomic analysis of human disease and its application to the eye.Metabolomics of bronchoalveolar lavage differentiate healthy HIV-1-infected subjects from controls.Metabolomics reveals altered metabolic pathways in experimental asthmaUntargeted LC-MS metabolomics of bronchoalveolar lavage fluid differentiates acute respiratory distress syndrome from health.Exploring airway diseases by NMR-based metabonomics: a review of application to exhaled breath condensate.Plasma lipidomics reveals potential prognostic signatures within a cohort of cystic fibrosis patients.Microbiota and metabolite profiling reveal specific alterations in bacterial community structure and environment in the cystic fibrosis airway during exacerbation.Metabolic Consequences of Chronic Alcohol Abuse in Non-Smokers: A Pilot StudyMetabolomics analysis identifies novel plasma biomarkers of cystic fibrosis pulmonary exacerbation.Metabolomic Evaluation of Neutrophilic Airway Inflammation in Cystic Fibrosis.Omics approaches in cystic fibrosis research: a focus on oxylipin profiling in airway secretions.Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients.Mini-bronchoalveolar lavage fluid can be used for biomarker identification in patients with lung injury by employing ¹H NMR spectroscopy.Pharmacogenetics and individualized therapy in children: immunosuppressants, antidepressants, anticancer and anti-inflammatory drugs.Application of metabolomics approaches to the study of respiratory diseases.Metabolomics perspectives in pediatric research.The metabolomics of airway diseases, including COPD, asthma and cystic fibrosis.Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis.Sialic acid-to-urea ratio as a measure of airway surface hydration.Lessons learned from metabolomics in cystic fibrosis.Metabolomics based predictive biomarker model of ARDS: A systemic measure of clinical hypoxemia.Multi-platform metabolomics assays for human lung lavage fluids in an air pollution exposure study.Serum and plasma amino acids as markers of prediabetes, insulin resistance, and incident diabetes.Official American Thoracic Society technical standards: flexible airway endoscopy in children.Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.Skin Biomarkers for Cystic Fibrosis: A Potential Non-Invasive Approach for Patient Screening.Metabolomic analysis of lung epithelial secretions in rats: an investigation of bronchoalveolar lavage fluid by GC-MS and FT-IR.Metabolomics as a tool for personalizing medicine: 2012 update.Metabolomic analysis of bronchoalveolar lavage fluid in preterm infants complicated by respiratory distress syndrome: preliminary results
P2860
Q21198748-0EDC7ED9-6361-4D49-8EAB-9162489EC0DEQ28829667-A971E185-22F1-47FE-B689-3D53180CAD99Q33631499-0FBA8B86-5244-47C4-BC13-72F92DFA0D77Q33713799-740FA623-D927-4218-8266-F0BD29A80648Q33756792-5D84AC6D-56AF-439D-BB46-3DD60A403108Q33799183-D6729B8F-7B40-440B-BA2F-E43323BE066CQ34700326-AC957181-A9E3-4F4F-9F9C-324E3BEDA5A1Q34776256-A3174F30-7BD7-40BC-A677-F9798CB8157AQ35072759-F7A9B21D-C836-4E55-B813-3626C73D6A5AQ35671702-2F575AD6-C227-4DF4-80B5-4D07503E53B2Q35675928-C6A7EE24-1918-4941-A5A2-1718A46EABFCQ35914614-6CA4BE47-63D8-444F-899B-7B33FAFBEE22Q36112019-D74CFA44-1239-409B-85E4-A03EAACE0AB5Q36142593-4ED73AC8-DA4E-4025-9A56-41F8516C9F4DQ36902428-82689C23-E891-4362-971D-1EFE1F5141BBQ37892531-D0D5AFCB-5CFB-4072-98D1-1CDAF923FB23Q38050515-AFC249AF-637E-429D-9275-931AA732AE3EQ38073595-9A64CFF2-31BC-4C27-9D4A-64B92C09FC4CQ38268820-54E3CC38-259D-466B-B1BE-F3E4EAFF2D35Q38796210-EA28DA33-A228-4CE8-A25F-8D6F5353DCB6Q40381848-B0A8BB5E-E613-46F7-B147-E8A93847DF2DQ40920707-3432BEAA-3F84-43FF-B0A2-3E025F3EE66BQ44003095-F219311A-AB8F-4906-80FC-861DC7005060Q46558164-607A5022-848E-4131-B982-7978C89942DCQ47312518-C101A29A-F485-4C48-BD04-C2CF229263CBQ47711743-399F1341-DD79-4D95-AB90-D8756CC9CD3CQ47831284-338E3E7D-B819-4845-ABD4-B74ADE9A2512Q48521376-72E4BD51-99BE-4B22-BC6E-EFEE21A6BB4FQ51702068-74731403-3725-45D7-B593-9051BB8716FEQ54257582-F1591B15-AAC7-4DD8-96BE-399622D95139Q57749236-199FBCCF-05B0-4A10-A085-D0E5D1BEE433
P2860
Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients.
@en
Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients.
@nl
type
label
Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients.
@en
Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients.
@nl
prefLabel
Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients.
@en
Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients.
@nl
P2093
P2860
P921
P1433
P1476
Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients.
@en
P2093
Charles R Esther
Justyna E Wolak
Thomas M O'Connell
P2860
P356
10.1080/13547500802688194
P577
2009-02-01T00:00:00Z